244 related articles for article (PubMed ID: 37868934)
1. The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?
Gunasekera CL; Sirven JI; Feyissa AM
J Cent Nerv Syst Dis; 2023; 15():11795735231209209. PubMed ID: 37868934
[TBL] [Abstract][Full Text] [Related]
2. Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.
Hersi H; Saarinen JT; Raitanen J; Peltola J
Front Neurol; 2022; 13():1042168. PubMed ID: 36438960
[TBL] [Abstract][Full Text] [Related]
3. Variation in seizure risk increases from antiseizure medication withdrawal among patients with well-controlled epilepsy: A pooled analysis.
Terman SW; Slinger G; Koek A; Skvarce J; Springer MV; Ziobro JM; Burke JF; Otte WM; Thijs RD; Lossius MI; Marson AG; Bonnett LJ; Braun KPJ
Epilepsia Open; 2024 Feb; 9(1):333-344. PubMed ID: 38071463
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed Epilepsy.
Hakeem H; Feng W; Chen Z; Choong J; Brodie MJ; Fong SL; Lim KS; Wu J; Wang X; Lawn N; Ni G; Gao X; Luo M; Chen Z; Ge Z; Kwan P
JAMA Neurol; 2022 Oct; 79(10):986-996. PubMed ID: 36036923
[TBL] [Abstract][Full Text] [Related]
5. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
[TBL] [Abstract][Full Text] [Related]
6. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study.
Hakeem H; Alsfouk BAA; Kwan P; Brodie MJ; Chen Z
Epilepsia; 2023 May; 64(5):1248-1258. PubMed ID: 36869855
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Rosenfeld WE; Nisman A; Ferrari L
Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
[TBL] [Abstract][Full Text] [Related]
8. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.
Smith MC; Klein P; Krauss GL; Rashid S; Seiden LG; Stern JM; Rosenfeld WE
Neurol Ther; 2022 Dec; 11(4):1705-1720. PubMed ID: 36057761
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological treatment of epilepsy in adults.
Tomson T; Zelano J; Dang YL; Perucca P
Epileptic Disord; 2023 Oct; 25(5):649-669. PubMed ID: 37386690
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Ryvlin P; Dimova S; Elmoufti S; Floricel F; Laloyaux C; Nondonfaz X; Biton V
Epilepsia; 2022 Aug; 63(8):2024-2036. PubMed ID: 35582748
[TBL] [Abstract][Full Text] [Related]
12. Shift from older- to newer-generation antiseizure medications in people with acute ischemic stroke in Australia: A population-based study.
Kim SJ; Wood S; Marquina C; Foster E; Bell JS; Ilomäki J
Epilepsia Open; 2023 Dec; 8(4):1413-1424. PubMed ID: 37574594
[TBL] [Abstract][Full Text] [Related]
13. Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation study.
Hadady L; Klivényi P; Perucca E; Rampp S; Fabó D; Bereczki C; Rubboli G; Asadi-Pooya AA; Sperling MR; Beniczky S
Eur J Neurol; 2022 Feb; 29(2):382-389. PubMed ID: 34741372
[TBL] [Abstract][Full Text] [Related]
14. [The Basis of Medication Therapy for Epilepsy].
Hanaya R
No Shinkei Geka; 2023 Jan; 51(1):95-104. PubMed ID: 36682754
[TBL] [Abstract][Full Text] [Related]
15. Anti-seizure medications for Lennox-Gastaut syndrome.
Brigo F; Jones K; Eltze C; Matricardi S
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
[TBL] [Abstract][Full Text] [Related]
16. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
Löscher W; Klein P
CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.
Alsfouk BAA; Brodie MJ; Walters M; Kwan P; Chen Z
JAMA Neurol; 2020 May; 77(5):574-581. PubMed ID: 32091535
[TBL] [Abstract][Full Text] [Related]
18. Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan.
Chiang KL; Liang CY; Hsieh LP; Chien LN
Seizure; 2021 Dec; 93():145-153. PubMed ID: 34768177
[TBL] [Abstract][Full Text] [Related]
19. Initiating antiepilepsy treatment: An update of expert consensus in Spain.
Villanueva V; Sánchez-Álvarez JC; Carreño M; Salas-Puig J; Caballero-Martínez F; Gil-Nagel A
Epilepsy Behav; 2021 Jan; 114(Pt A):107540. PubMed ID: 33243687
[TBL] [Abstract][Full Text] [Related]
20. Electroencephalographic seizures in critically ill children: Management and adverse events.
Fung FW; Jacobwitz M; Vala L; Parikh D; Donnelly M; Xiao R; Topjian AA; Abend NS
Epilepsia; 2019 Oct; 60(10):2095-2104. PubMed ID: 31538340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
